Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blackstone
MedTech
Longtime Hologic CEO MacMillan to retire as $18.3B deal closes
Hologic President and CEO Steve MacMillan is stepping down after nearly 13 years, marking the end of an era for the medtech company.
Ben Adams
Apr 7, 2026 9:57am
Blackstone closes record $6.3B life sciences fund
Mar 30, 2026 1:50pm
Teva's $400M Blackstone deal to fund Sanofi-partnered IBD drug
Mar 4, 2026 3:07am
Ovid eyes next chapter with CEO transition—Chutes & Ladders
Nov 14, 2025 8:30am
Merck bags $700M from Blackstone, spends $150M to regain asset
Nov 4, 2025 9:15am
Hologic to go private with $18.3B deal by Blackstone and TPG
Oct 22, 2025 8:45am
